Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 163423, 8 pages
http://dx.doi.org/10.1155/2015/163423
Clinical Study

Prognostic Outcomes and Risk Factors for Patients with Renal Cell Carcinoma and Venous Tumor Thrombus after Radical Nephrectomy and Thrombectomy: The Prognostic Significance of Venous Tumor Thrombus Level

1Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing 100034, China
2Department of Urology, University of California, San Francisco, CA 94143-0738, USA
3Department of Cardiac Surgery, Peking University First Hospital, Beijing 100034, China

Received 22 November 2014; Accepted 24 April 2015

Academic Editor: Stefan Zastrow

Copyright © 2015 Qi Tang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, E. Ward, O. Brawley, and A. Jemal, “Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths,” CA: A Cancer Journal for Clinicians, vol. 61, no. 4, pp. 212–236, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. N. C. Center, Chinese Cancer Registry Annual Report, Military Medical Science Press, Beijing, China, 2012.
  3. V. Ficarra, R. Righetti, A. D'amico et al., “Renal vein and vena cava involvement does not affect prognosis in patients with renal cell carcinoma,” Oncology, vol. 61, no. 1, pp. 10–15, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Parra, S. J. Drouin, V. Hupertan, E. Comperat, M. O. Bitker, and M. Rouprêt, “Oncological outcomes in patients undergoing radical nephrectomy and vena cava thrombectomy for renal cell carcinoma with venous extension: a single-centre experience,” European Journal of Surgical Oncology, vol. 37, no. 5, pp. 422–428, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Haferkamp, P. J. Bastian, H. Jakobi et al., “Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup,” Journal of Urology, vol. 177, no. 5, pp. 1703–1708, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Rigaud, J.-F. Hetet, G. Braud et al., “Surgical care, morbidity, mortality and follow-up after nephrectomy for renal cancer with extension of tumor thrombus into the inferior vena cava: retrospective study since 1990s,” European Urology, vol. 50, no. 2, pp. 302–310, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. L. Blute, B. C. Leibovich, C. M. Lohse, J. C. Cheville, and H. Zincke, “The Mayo-Clinic experience with surgical management complications and outcome for patients with renal cell carcinoma and venous tumour thrombus,” BJU International, vol. 94, no. 1, pp. 33–41, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. I. M. Varkarakis, S. B. Bhayani, M. E. Allaf, T. Inagaki, M. L. Gonzalgo, and T. W. Jarrett, “Laparoscopic-assisted nephrectomy with inferior vena cava tumor thrombectomy: preliminary results,” Urology, vol. 64, no. 5, pp. 925–929, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. A. N. Hoang, A. A. Vaporcyian, and S. F. Matin, “Laparoscopy-assisted radical nephrectomy with inferior vena caval thrombectomy for level II to III tumor thrombus: a single-institution experience and review of the literature,” Journal of Endourology, vol. 24, no. 6, pp. 1005–1012, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. I. Martínez-Salamanca, W. C. Huang, I. Millán et al., “Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension,” European Urology, vol. 59, no. 1, pp. 120–127, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Wagner, J.-J. Patard, A. Méjean et al., “Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma,” European Urology, vol. 55, no. 2, pp. 452–460, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Moinzadeh and J. A. Libertino, “Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same?” Journal of Urology, vol. 171, no. 2, pp. 598–601, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Zhang, X. Li, H. Hao, W. Yu, Z. He, and L. Zhou, “The correlation between size of renal cell carcinoma and its histopathological characteristics: a single center study of 1867 renal cell carcinoma cases,” BJU International, vol. 110, no. 11, pp. E481–E485, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. H. L. Kim, A. Zisman, K.-R. Han, R. A. Figlin, and A. S. Belldegrun, “Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different?” Journal of Urology, vol. 171, no. 2, pp. 588–591, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Ficarra, A. Galfano, M. Mancini, G. Martignoni, and W. Artibani, “TNM staging system for renal-cell carcinoma: current status and future perspectives,” The Lancet Oncology, vol. 8, no. 6, pp. 554–558, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Ficarra, G. Novara, M. Iafrate et al., “Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3-4) renal cell carcinoma according to the cancer-related outcome,” European Urology, vol. 51, no. 3, pp. 722–731, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. R. H. Thompson, J. C. Cheville, C. M. Lohse et al., “Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy,” Cancer, vol. 104, no. 1, pp. 53–60, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. R. J. Neves and H. Zincke, “Surgical treatment of renal cancer with vena cava extension,” British Journal of Urology, vol. 59, no. 5, pp. 390–395, 1987. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Klatte, A. J. Pantuck, S. B. Riggs et al., “Prognostic factors for renal cell carcinoma with tumor thrombus extension,” Journal of Urology, vol. 178, no. 4, pp. 1189–1195, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. A. A. Glazer and A. C. Novick, “Long-term followup after surgical treatment for renal cell carcinoma extending into the right atrium,” Journal of Urology, vol. 155, no. 2, pp. 448–450, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. D. G. Skinner, T. R. Pritchett, G. Lieskovsky, S. D. Boyd, and Q. R. Stiles, “Vena caval involvement by renal cell carcinoma: surgical resection provides meaningful long-term survival,” Annals of Surgery, vol. 210, no. 3, pp. 387–394, 1989. View at Publisher · View at Google Scholar · View at Scopus
  22. N. K. Bissada, H. H. Yakout, A. Babanouri et al., “Long-term experience with management of renal cell carcinoma involving the inferior vena cava,” Urology, vol. 61, no. 1, pp. 89–92, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Xu, Q. Zhao, J. Jin, Z.-S. He, L.-Q. Zhou, and Q. Zhang, “Laparoscopic versus open surgery for renal masses with infrahepatic tumor thrombus: the largest series of retroperitoneal experience from China,” Journal of Endourology, vol. 28, no. 2, pp. 201–207, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. Q. Tang, T. Wang, X. Li et al., “Renal cell carcinoma with infrahepatic vena caval tumor thrombus treated with a novel combined retroperitoneal and transperitoneal pure laparoscopic procedure,” Urology, vol. 83, no. 5, pp. e9–e10, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. P. I. Karakiewicz, N. Suardi, C. Jeldres et al., “Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi,” European Urology, vol. 53, no. 4, pp. 845–848, 2008. View at Google Scholar
  26. N. G. Cost, S. E. Delacroix Jr., J. P. Sleeper et al., “The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus,” European Urology, vol. 59, no. 6, pp. 912–918, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. X.-S. Li, X. Wu, P.-J. Zhao et al., “Efficacy and safety of sunitinib in the treatment of metastatic renal cell carcinoma,” Chinese Medical Journal, vol. 124, no. 18, pp. 2920–2924, 2011. View at Publisher · View at Google Scholar · View at Scopus